| 000 | 01490 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513192112.0 | ||
| 264 | 0 | _c19990929 | |
| 008 | 199909s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSilver, R T | |
| 245 | 0 | 0 |
_aAn evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology. _h[electronic resource] |
| 260 |
_bBlood _cSep 1999 |
||
| 300 |
_a1517-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aBone Marrow Transplantation |
| 650 | 0 | 4 |
_aBusulfan _xadverse effects |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxyurea _xadverse effects |
| 650 | 0 | 4 |
_aInterferon-alpha _xadverse effects |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xtherapy |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 700 | 1 | _aWoolf, S H | |
| 700 | 1 | _aHehlmann, R | |
| 700 | 1 | _aAppelbaum, F R | |
| 700 | 1 | _aAnderson, J | |
| 700 | 1 | _aBennett, C | |
| 700 | 1 | _aGoldman, J M | |
| 700 | 1 | _aGuilhot, F | |
| 700 | 1 | _aKantarjian, H M | |
| 700 | 1 | _aLichtin, A E | |
| 700 | 1 | _aTalpaz, M | |
| 700 | 1 | _aTura, S | |
| 773 | 0 |
_tBlood _gvol. 94 _gno. 5 _gp. 1517-36 |
|
| 999 |
_c10435097 _d10435097 |
||